We are delighted to announce the WiScope® single-use digital flexible cystoscope, which recently received EU approval and is based on the same imaging platform as a WiScope® single-use flexible digital ureteroscope.

As the global infection rates of COVID-19 continue to rise, investigators in Italy, led by Erika Poggiali, M.D., from Ospedale Guglielmo da Saliceto, evaluated whether lung ultrasound could be an effective tool in also identifying patients who have pneumonia specifically associated with the virus. They published their results in a Letter to the Editor recently in Radiology.

We continue to monitor the COVID-19 outbreak and are adjusting our business practice in line with directives from the BAG and WHO. It is our goal to give ongoing support to our customers while at the same time ensuring the safety and health of our team members.

At the ASCO Genitourinary Cancers Symposium 2020 in San Francisco, Prof. Thomas-Alexander Vögeli from the University Hospital RWTH Aachen, Germany presented very promising results of first two year follow up after the Hyperthermic Intra-VEsical Chemotherapy (HIVEC) with heated mitomycin in a cohort of patients with high risk superficial bladder cancer (TCC).

Impressive results of the COMPARE study have recently been published in The Journal of Urology. Prostate cancer patients of all risk groups were willing to trade-off cancer-specific survival for improved quality of life.

As 2019 comes to an end, this is our time to say thank you.

Two great papers, recently published in European Urology, confirm that MRI-targeted biopsy is the attractive and reliable diagnostic strategy for prostate cancer compared to the traditional diagnostic pathway of systematic TRUS biopsy.

New strong clinical data for Sonablate HIFU, recently published in the BJU International, confirms very promising medium-term oncological outcomes.

At the AUA congress in Chicago, Prof. Leonard Marks and the UCLA group presented a method for focal HIFU, employing multiparametric magnetic resonance imaging, fusion biopsy, margin generation, and targeted treatment.

We are delighted to announce a new partnership with OTU Medical Inc., a Silicon Valley based medical technology company, which recently received the EU approval for its second generation WiScope® single-use flexible digital ureteroscope.

We’re pleased to announce that the Prostate Imaging and Focal Therapy Masterclass, presented by one of the world’s leading urologists and experts in focal therapy, Prof. Hashim Ahmed, Chair of Urology of Imperial College London, will be returning on the 5-6th April 2019 for its second event.

SonoIQ, a small pocket Ultrasound, transfers high resolution ultrasound images to Android, iOS or Windows smartphone or tablet via WiFi or USB cable.